BCL6-IN-6
BCL6-IN-6 is a potent inhibitor of transcriptional repressor B-cell lymphoma 6 (BCL6) . BCL6-IN-6 significantly blocks the interaction of BCL6 with its corepressors and reactivates BCL6 target genes in a dose-dependent manner. BCL6-IN-6 has the potential for the research of diffuse large B-cell lymphoma (DLBCL) [1].
Product Specifications
CAS Number
2408882-54-0
UNSPSC
12352005
Target
BCL6
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bcl6-in-6.html
Purity
98.10
Solubility
DMSO : ≥ 4 mg/mL
Smiles
O=C(C1=CC=C(C2=CCCC2)S1)NC3=CC=C(NC4=NC(N5C[C@@H](C)N[C@@H](C)C5)=NC=C4F)C=C3OC
Molecular Formula
C27H31FN6O2S
Molecular Weight
522.64
References & Citations
[1]Guo W, et al. Synthesis and Biological Evaluation of B-Cell Lymphoma 6 Inhibitors of N-Phenyl-4-pyrimidinamine Derivatives Bearing Potent Activities against Tumor Growth. J Med Chem. 2020;63 (2) :676-695.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-UNEL-H0159-01 5x 96 Tests
Uncoated Human PDGF-AB (Platelet Derived Growth Factor AB) ELISA Kit
Sign In for Pricing
View Details E-UNEL-H0159-02 15x 96 Tests
Uncoated Human PDGF-AB (Platelet Derived Growth Factor AB) ELISA Kit
Sign In for Pricing
View Details 
